Immunotoxicology is the study of immune dysfunction resulting from exposure of an organism to a xenobiotic agents. The immune dysfunction may take the form of immunosuppression or alternatively, allergy, autoimmunity or any number of inflammatory-based diseases and pathologies. In the non-adult (embryo, fetus, neonate, juvenile, adolescent) this study is referred to as Developmental Immunotoxicology (commonly abbreviated as DIT). For most toxicants examined to date, the developing immune system exhibits a heightened sensitivity compared with that of an adult. For this reason, DIT screening has applications to human, animal and wildlife health protection. Immunotoxicological responses sometimes leads to extreme health conditions, as we know it is an immunodisfunction problem it becomes fatal. Different people give different type of response to a certain drug as it gets interacted with their immune system. Some people show hypersensitivity to a specific drug.


  • Track 1-1 Pharmacodynamics and pharmacokinetics
  • Track 2-2 Ethical and legal issues
  • Track 3-3 Drug screening and discovery
  • Track 4-4 Drug-drug interactions
  • Track 5-5 Pharmacovigilance

Related Conference of Toxicology